BRPI0915487A2 - hemaglutina de nfluenza e variantes de neuraminidase - Google Patents

hemaglutina de nfluenza e variantes de neuraminidase

Info

Publication number: BRPI0915487A2
Authority: BR; Brazil
Prior art keywords: nfluenza; hemagglutin; neuraminidase variants; neuraminidase; variants
Prior art date: 2008-07-11

Application number

BRPI0915487A

Other languages

English (en)

Inventor

Yang Chin-Fen

Kemble George

Original Assignee

Medimmune Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-11

Filing date

2009-07-09

Publication date

2017-06-27

2009-07-09 Application filed by Medimmune Inc filed Critical Medimmune Inc

2017-06-27 Publication of BRPI0915487A2 publication Critical patent/BRPI0915487A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16161—Methods of inactivation or attenuation
- C12N2760/16162—Methods of inactivation or attenuation by genetic engineering
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16261—Methods of inactivation or attenuation
- C12N2760/16262—Methods of inactivation or attenuation by genetic engineering

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0915487A 2008-07-11 2009-07-09 hemaglutina de nfluenza e variantes de neuraminidase BRPI0915487A2 (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US7989408P	2008-07-11	2008-07-11
US11070208P	2008-11-03	2008-11-03
US17859209P	2009-05-15	2009-05-15
PCT/US2009/050070 WO2010006144A2 (en)	2008-07-11	2009-07-09	Influenza hemagglutinin and neuraminidase variants

Publications (1)

Publication Number	Publication Date
BRPI0915487A2 true BRPI0915487A2 (pt)	2017-06-27

Family

ID=41507727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0915487A BRPI0915487A2 (pt)	2008-07-11	2009-07-09	hemaglutina de nfluenza e variantes de neuraminidase

Country Status (11)

Country	Link
US (1)	US8591914B2 (pt)
EP (2)	EP2574344A1 (pt)
JP (2)	JP2011527581A (pt)
CN (1)	CN102149405A (pt)
AU (1)	AU2009268576B2 (pt)
BR (1)	BRPI0915487A2 (pt)
CA (1)	CA2730408A1 (pt)
MX (1)	MX2011000437A (pt)
RU (1)	RU2523587C2 (pt)
SG (1)	SG192501A1 (pt)
WO (1)	WO2010006144A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2529647C (en)	2003-06-16	2013-08-13	Medimmune Vaccines, Inc.	Influenza hemagglutinin and neuraminidase variants
ES2527503T3 (es)	2005-03-08	2015-01-26	Medimmune, Llc	Virus influenza reordenantes
CN101472941B (zh)	2006-03-31	2017-08-08	沃弗-威斯康星校友研究基金会	用于疫苗的高滴度重组流感病毒
US9474798B2 (en)	2007-06-18	2016-10-25	Wisconsin Alumni Research Foundation	Influenza M2 protein mutant viruses as live influenza attenuated vaccines
JP2011527581A (ja)	2008-07-11	2011-11-04	メディミューン，エルエルシー	インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体
EP2493912B1 (en)	2009-10-26	2020-07-29	Wisconsin Alumni Research Foundation	High titer recombinant influenza viruses with enhanced replication in vero cells
US10130697B2 (en)	2010-03-23	2018-11-20	Wisconsin Alumni Research Foundation (Warf)	Vaccines comprising mutant attenuated influenza viruses
AU2012289926A1 (en) *	2011-08-03	2014-03-13	Children's Medical Center Corporation	A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
WO2013032942A1 (en)	2011-08-26	2013-03-07	Yoshihiro Kawaoka	Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
US9969794B2 (en)	2012-05-10	2018-05-15	Visterra, Inc.	HA binding agents
AU2014204826A1 (en) *	2013-01-10	2015-07-09	Seqirus UK Limited	Influenza virus immunogenic compositions and uses thereof
AU2014229255B2 (en)	2013-03-13	2018-12-13	Novartis Ag	Influenza B virus reassortment
US20140286981A1 (en) *	2013-03-14	2014-09-25	Wisconsin Alumni Research Foundation	Broadly reactive mosaic peptide for influenza vaccine
US9950057B2 (en)	2013-07-15	2018-04-24	Wisconsin Alumni Research Foundation (Warf)	High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
WO2015061475A2 (en)	2013-10-22	2015-04-30	THE GOVERNMENT OF THE USA as represented by THE SECRETARY OF THE DEPARTMENT OF HEATLH AND HUMAN SERV	Compositions and methods for detection and discrimination of influenza viruses
WO2015196150A2 (en)	2014-06-20	2015-12-23	Wisconsin Alumni Research Foundation (Warf)	Mutations that confer genetic stability to additional genes in influenza viruses
US10633422B2 (en)	2015-06-01	2020-04-28	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
US9890363B2 (en)	2015-07-06	2018-02-13	Wisconsin Alumni Research Foundation (Warf)	Influenza virus replication for vaccine development
US10513553B2 (en)	2015-11-13	2019-12-24	Visterra, Inc.	Compositions and methods for treating and preventing influenza
CA3014435C (en)	2016-02-19	2023-04-18	Wisconsin Alumni Research Foundation (Warf)	Improved influenza b virus replication for vaccine development
EP3419663A1 (en)	2016-02-24	2019-01-02	Visterra, Inc.	Formulations of antibody molecules to influenza virus
US11197926B2 (en)	2017-10-25	2021-12-14	Wisconsin Alumni Research Foundation (Warf)	Recombinant influenza viruses with stabilized HA for replication in eggs
CN108018300B (zh)	2017-11-21	2020-08-28	浙江迪福润丝生物科技有限公司	区分免疫和感染动物h7亚型禽流感疫苗株及其制备方法和应用
CN108048476B (zh) *	2017-11-21	2020-09-08	浙江迪福润丝生物科技有限公司	一种制备区分免疫和感染动物h9亚型禽流感疫苗株的方法及应用
JP7783047B2 (ja)	2018-08-07	2025-12-09	ウィスコンシンアルムニリサーチファンデイション	組換えの生物学的に封じ込められたフィロウイルスワクチン
WO2020041311A1 (en)	2018-08-20	2020-02-27	Wisconsin Alumni Research Foundation	Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein
EP3914295A2 (en)	2019-01-23	2021-12-01	Yoshihiro Kawaoka	Mutations that confer genetic stability to additional genes in influenza viruses
US11851648B2 (en)	2019-02-08	2023-12-26	Wisconsin Alumni Research Foundation (Warf)	Humanized cell line
WO2020198329A1 (en)	2019-03-25	2020-10-01	Visterra, Inc.	Compositions and methods for treating and preventing influenza
WO2020223699A1 (en)	2019-05-01	2020-11-05	Wisconsin Alumni Research Foundation (Warf)	Improved influenza virus replication for vaccine development
JP7627911B2 (ja)	2019-08-27	2025-02-07	ウィスコンシンアルムニリサーチファンデイション	卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
US11739303B2 (en)	2020-01-24	2023-08-29	Wisconsin Alumni Research Foundation (Warf)	Recombinant influenza viruses with stabilized NA
US12290562B2 (en)	2020-03-25	2025-05-06	Wisconsin Alumni Research Foundation (Warf)	Recombinant multivalent influenza viruses

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3992522A (en) *	1973-01-24	1976-11-16	The United States Of America As Represented By The Department Of Health, Education And Welfare	Temperature-sensitive recombinant mutant viruses and a process for producing same
US4071618A (en) *	1974-09-03	1978-01-31	Research Foundation For Microbial Diseases Of Osaka University	Process for preparing virus disease live vaccines
JPS57136528A (en) *	1981-02-09	1982-08-23	Hayashibara Biochem Lab Inc	Preparation of viral vaccine
CH652145A5 (de)	1982-01-22	1985-10-31	Sandoz Ag	Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4634666A (en) *	1984-01-06	1987-01-06	The Board Of Trustees Of The Leland Stanford Junior University	Human-murine hybridoma fusion partner
US5202238A (en)	1987-10-27	1993-04-13	Oncogen	Production of chimeric antibodies by homologous recombination
US5166057A (en)	1989-08-28	1992-11-24	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand rna virus expression-systems
US5840520A (en)	1989-08-28	1998-11-24	Aviron	Recombinant negative strand RNA virus expression systems
US6001634A (en) *	1989-08-28	1999-12-14	Palese; Peter	Recombinant negative strand RNA viruses
US5854037A (en) *	1989-08-28	1998-12-29	The Mount Sinai School Of Medicine Of The City University Of New York	Recombinant negative strand RNA virus expression systems and vaccines
WO1993021306A1 (en)	1992-04-14	1993-10-28	The Mount Sinai School Of Medicine Of The City University Of New York	Genetically engineered attenuated viruses
IL105456A (en) *	1992-04-21	1996-12-05	American Home Prod	Vaccines of attenuated respiratory syncytial virus
US5762939A (en)	1993-09-13	1998-06-09	Mg-Pmc, Llc	Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
DE69532369T3 (de)	1994-07-18	2010-11-04	Conzelmann, Karl-Klaus, Prof. Dr.	Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
US5716821A (en) *	1994-09-30	1998-02-10	Uab Research Foundation	Prevention and treatment of respiratory tract disease
US5789229A (en) *	1994-09-30	1998-08-04	Uab Research Foundation	Stranded RNA virus particles
US6146873A (en) *	1994-11-10	2000-11-14	Baxter Aktiengesellschaft	Production of orthomyxoviruses in monkey kidney cells using protein-free media
US7153510B1 (en)	1995-05-04	2006-12-26	Yale University	Recombinant vesiculoviruses and their uses
US5690937A (en) *	1995-06-05	1997-11-25	Aviron	Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
DE69510207T3 (de)	1995-08-09	2007-02-15	Schweiz. Serum- & Impfinstitut Bern	Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
WO1997012032A1 (en)	1995-09-27	1997-04-03	The Government Of The United States Of America, As Represented By The Department Of Health And Human Services	Production of infectious respiratory syncytial virus from cloned nucleotide sequences
RU2100033C1 (ru) *	1995-10-05	1997-12-27	Санкт-Петербургский научно-исследовательский институт вакцин и сывороток	Способ получения вакцинных штаммов вируса гриппа в для производства инактивированных и живых гриппозных вакцин
EP0864645B9 (en)	1995-10-31	2006-03-22	Dnavec Research Inc.	Negative-strand rna virus vector having autonomously replicating activity
AU7335296A (en)	1995-11-01	1997-05-22	Dnavec Research Inc.	Recombinant sendai virus
US6090391A (en) *	1996-02-23	2000-07-18	Aviron	Recombinant tryptophan mutants of influenza
AU3799797A (en)	1996-07-15	1998-02-09	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
KR20000048628A (ko)	1996-09-27	2000-07-25	윌리암 에이취 캘넌, 에곤 이 버그	모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이
CN1250725C (zh)	1997-05-23	2006-04-12	美国政府健康及人类服务部	从克隆的核苷酸序列制备减毒副流感病毒疫苗的方法
PT1012244E (pt)	1997-07-11	2007-08-21	Univ Yale	''rabdovírus com revestimentos remanipulados''
JP2001517448A (ja)	1997-09-19	2001-10-09	アメリカン・サイアナミド・カンパニー	弱毒化呼吸合胞体ウイルス
US6146642A (en) *	1998-09-14	2000-11-14	Mount Sinai School Of Medicine, Of The City University Of New York	Recombinant new castle disease virus RNA expression systems and vaccines
US6544785B1 (en)	1998-09-14	2003-04-08	Mount Sinai School Of Medicine Of New York University	Helper-free rescue of recombinant negative strand RNA viruses
EP1035209A1 (en)	1999-03-06	2000-09-13	ARTEMIS Pharmaceuticals GmbH	Stable recombinant influenza viruses free of helper viruses
DE60035778T2 (de)	1999-04-06	2008-04-30	Wisconsin Alumni Research Foundation, Madison	Rekombinante influenzaviren zur vakzinherstellung und gentherapie
US8715940B2 (en) *	1999-04-06	2014-05-06	Wisconsin Alumni Research Foundation	Method of making recombinant influenza virus
ATE299943T1 (de) *	2000-03-02	2005-08-15	Polymun Scient Immunbio Forsch	Rekombinantes influenza a virus
NZ521840A (en) *	2000-04-28	2004-11-26	St	Development of a multi-plasmid pol I - pol II based system for the generation of infectious influenza RNA viruses from cloned DNA
AU2002223560B2 (en) *	2000-09-25	2006-06-29	Polymun Scientific Immunbiologische Forschung Gmbh	Live influenza vaccine and method of manufacture
ATE503493T1 (de) *	2001-02-23	2011-04-15	Glaxosmithkline Biolog Sa	Influenza vakzinzusammensetzungen zur intradermaler verabreichung
US7465456B2 (en) *	2002-04-26	2008-12-16	Medimmune, Llc	Multi plasmid system for the production of influenza virus
ES2526191T3 (es) *	2002-04-26	2015-01-08	Medimmune, Llc	Método para producir virus influenza B infeccioso en cultivo celular
CN100482788C (zh) *	2003-04-10	2009-04-29	中国疾病预防控制中心病毒病预防控制所	高产的重组乙型流感病毒株及其用途
CA2529647C (en)	2003-06-16	2013-08-13	Medimmune Vaccines, Inc.	Influenza hemagglutinin and neuraminidase variants
US7037707B2 (en) *	2003-09-04	2006-05-02	St. Jude Children's Research Hospital	Method for generating influenza viruses and vaccines
CN1644686B (zh) *	2003-10-08	2010-05-12	中国疾病预防控制中心病毒病预防控制所	流感病毒哺乳动物细胞高产毒株、其重组毒株及其制备方法和应用
ES2393492T3 (es)	2004-05-25	2012-12-21	Medimmune, Llc	Variantes de hemaglutinina y neuraminidasa de influenza
ES2382446T3 (es)	2004-11-01	2012-06-08	Eiken Kagaku Kabushiki Kaisha	Método de detección del virus de la gripe aviar H5
WO2006062637A2 (en) *	2004-11-03	2006-06-15	Novartis Vaccines And Diagnostics Inc.	Influenza vaccination
DK2368975T3 (en) *	2004-12-23	2015-01-05	Medimmune Llc	Non-tumorigenic MDCK cell line for the propagation of viruses
ES2527503T3 (es) *	2005-03-08	2015-01-26	Medimmune, Llc	Virus influenza reordenantes
ES2555544T3 (es) *	2006-03-07	2016-01-04	Vaxinnate Corporation	Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
US20090017052A1 (en) *	2007-01-18	2009-01-15	Samuel Bogoch	Methods of determining lethality of pathogens and malignancies involving replikin peak genes
CA2615372A1 (en) *	2007-07-13	2009-01-13	Marc-Andre D'aoust	Influenza virus-like particles (vlps) comprising hemagglutinin
JP2011527581A (ja)	2008-07-11	2011-11-04	メディミューン，エルエルシー	インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体

2009
- 2009-07-09 JP JP2011517611A patent/JP2011527581A/ja active Pending
- 2009-07-09 MX MX2011000437A patent/MX2011000437A/es active IP Right Grant
- 2009-07-09 EP EP12177899A patent/EP2574344A1/en not_active Withdrawn
- 2009-07-09 SG SG2013053277A patent/SG192501A1/en unknown
- 2009-07-09 CN CN200980135949XA patent/CN102149405A/zh active Pending
- 2009-07-09 US US13/003,559 patent/US8591914B2/en not_active Expired - Fee Related
- 2009-07-09 WO PCT/US2009/050070 patent/WO2010006144A2/en not_active Ceased
- 2009-07-09 AU AU2009268576A patent/AU2009268576B2/en not_active Ceased
- 2009-07-09 BR BRPI0915487A patent/BRPI0915487A2/pt not_active IP Right Cessation
- 2009-07-09 RU RU2011104999/10A patent/RU2523587C2/ru not_active IP Right Cessation
- 2009-07-09 EP EP09795168A patent/EP2318043A4/en not_active Withdrawn
- 2009-07-09 CA CA2730408A patent/CA2730408A1/en not_active Abandoned
2014
- 2014-04-11 JP JP2014081534A patent/JP2014158487A/ja active Pending

Also Published As

Publication number	Publication date
EP2574344A1 (en)	2013-04-03
CN102149405A (zh)	2011-08-10
AU2009268576B2 (en)	2014-03-27
EP2318043A2 (en)	2011-05-11
WO2010006144A2 (en)	2010-01-14
SG192501A1 (en)	2013-08-30
RU2523587C2 (ru)	2014-07-20
CA2730408A1 (en)	2010-01-14
RU2011104999A (ru)	2012-08-20
JP2014158487A (ja)	2014-09-04
US8591914B2 (en)	2013-11-26
MX2011000437A (es)	2012-03-07
US20110212117A1 (en)	2011-09-01
JP2011527581A (ja)	2011-11-04
AU2009268576A1 (en)	2010-01-14
EP2318043A4 (en)	2012-01-25
WO2010006144A3 (en)	2010-03-18

Publication	Publication Date	Title
BRPI0915487A2 (pt)	2017-06-27	hemaglutina de nfluenza e variantes de neuraminidase
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
BRPI0912271A2 (pt)	2015-10-20	co-autoria estruturada
BRPI0906764A2 (pt)	2015-08-18	Processos
EP2298731A4 (en)	2011-09-21	AMIDE COMPOUND
EP2329442A4 (en)	2013-07-24	PREDICTIVE GEOTEMPORAL TARGETING OF ADVERTISING CONTENT
BRPI0924512A2 (pt)	2016-03-01	método e aparelho de fornecimento de execução de aplicativos seguros
EP2351549A4 (en)	2015-06-24	INTERCONNECTS
EP2305405A4 (en)	2012-02-01	COATED ELEMENT
BRPI0908116A2 (pt)	2015-10-06	pulverizador
BRPI0906959A2 (pt)	2015-07-14	Variantes de celulase com inibição reduzida por glicose
BRPI0906888A2 (pt)	2015-11-03	derivado de fenilacetamida
BR112012010242A2 (pt)	2015-09-29	derivados de heteroarilpiperidina e heteroarilpiperazina
FI20090357L (fi)	2011-03-29	Menetelmä ja järjestely
FI20106126L (fi)	2010-10-28	Kuvantaja
DK2310037T3 (da)	2014-10-27	Conglutin-gamma as-medikament og -kosttilskudpatentkrav
FI20096360A0 (fi)	2009-12-18	Bioliima ja puulevy
ES1069154Y (es)	2009-05-12	Mecanismo escurridor de fregona
FI20095225A0 (fi)	2009-03-06	Kiinnitysväline ja kiinnitysjärjestelmä
ITMI20080469A1 (it)	2009-09-20	X
ES1068055Y (es)	2008-11-01	Expositor de joyeria
UA17379S (uk)	2008-09-25	Вивіска
UA17401S (uk)	2008-09-25	Вивіска
UA18808S (uk)	2009-04-27	Вивіска
UA17381S (uk)	2008-09-25	Вивіска

Legal Events

Date	Code	Title	Description
2017-07-11	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 7A E 8A ANUIDADES.
2017-10-31	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]